ClexBio
ClexBio is a biotech company creating breakthrough solutions for tissue engineering and single-cell techniques by combining advanced microfluidics with our proprietary hydrogel technology CLEX.
Oslo, Norwaywww.clexbio.com ↗
Total raised
€1.9M
€1,867,877
Funding rounds
1
Investors
5
distinct backers
Active since
2021-07
latest 2021-07
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-07-22 | Seed | €1.9M | Angel Investors,Centre for Digital Life Norway,Innovation Norway,Research Council of Norway,UK Engineering and Physical Sciences Research Council | View deal → |
Investors
5Related news
- ClexBio Raises USD 2.2M in Financingt.co · 2021-07
Similar companies
same sector or country- Visma€3.0BNorway · Software
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Adevinta€1.9BNorway · Marketing
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech